How effective is dasatinib?

Dasatinib(Dasatinib) is an oral, short-acting inhibitor of multiple tyrosine kinases. Dasatinib is a highly potent BCR-ABLinhibitor and is the BCR-ABL driver disease chronic myelogenous leukemia(CML)and Philadelphia chromosome-positive acute lymphoblastic leukemia(Ph+ An effective treatment for ALL) characterized by a constitutively active tyrosine kinaseBCR-ABL.

Dasatinib(Dasatinib)How effective is it?

In a long follow-up, dasatinib treatment produced significant hematological and cytogenetic response rates. 42% (15/36)of patients experienced a major hematologic response, of which 67% remained progression-free. 58% (21/36)of patients achieved a complete cytogenetic response.

Dasatinib was approved for use in the United States in June 2006 and in the European Union in November 2006. In October 2010, dasatinib was approved in the United States for the treatment of newly diagnosed adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (CP-CML). In November 2017, dasatinib was approved in the United States for the treatment of children with chronic phase Philadelphia chromosome-positive (Ph+)chronic myeloid leukemia(CML). DasatinibTablets are white to off-white biconvex film-coated tablets containing dasatinib and the following inactive ingredients:Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hydroxypropylcellulose, and magnesium stearate. The tablet coating consists of hypromellose, titanium dioxide, and polyethylene glycol. There are generic drugs overseas, and the Indian version costs around four to five hundred per box. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.